Ocera Therapeutics Inc (NASDAQ:OCRX)

5.40
Data as of 3:59pm ET
 -0.11 / -2.00%
Today’s Change
5.30
Today|||52-Week Range
19.94
-58.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$108.7M

Company Description

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002 ornithine phenylacetate. The OCR-002 is an ammonia scavenger which is used to treat hyperammonemia and associated hepatic encephalopathy in patients with liver cirrhosis, acute liver failure and acute liver injury. The company was founded by Wu Xiaoyun and John C. Kappes on January 12, 1998 and is headquarterd in Palo Alto, CA.

Contact Information

Ocera Therapeutics, Inc.
525 University Avenue
Palo Alto California 94301
P:(650) 475-0150
Investor Relations:

Employees

Shareholders

Other institutional35.78%
Individual stakeholders2.32%
Mutual fund holders2.06%

Top Executives

Linda S. GraisPresident, Chief Executive Officer & Director
Sharon E. TetlowTreasurer, Chief Financial & Accounting Officer
Franck S. RousseauDirector, Chief Medical & Development Officer
Gaurav AggarwalChief Business Officer
Jeryl L. HillemanChief Accounting Officer & Head-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.